Moreover, it was confirmed that a knockdown of PDAM in glioma cells induced cisplatin resistance mainly because of the up-regulation of the anti-apoptotic gene, BCL2-like 1 (BCL2L1) [16]. Here, BCL2L1 is linked to central nervous system cancer.